Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Concurrent radiotherapy with gefitinib in elderly patients with esophageal squamous cell carcinoma: Preliminary results of a phase II study.

Oncotarget - 10 Nov 2015

Xu Yaping, Zheng Yuanda, Sun Xiaojiang, Yu Xinmin, Gu Jialei, Wu Wei, Zhang Gu, Hu Jinlin, Sun Wenyong, Mao Weimin

Abstract excerpt

The survival rate associated with esophageal cancer is very poor due to diagnosis at advanced stages of disease and insensitivity to chemotherapy. This study investigated the efficacy of gefitinib combination with radiation in 20 elderly patients with esophageal squamous cell carcinoma (ESCC) who were not eligible for platinum-based chemotherapy. Immunohistochemistry was performed to analyze epidermal growth...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemoradiotherapy
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Esophageal Neoplasms

Share to Esophageal Squamous Cell Carcinoma

Share to Gefitinib

Share to Kaplan-Meier Estimate

Share to Quinazolines

Share to Tomography, X-Ray Computed

Source

Open in PubMed Open full text

Identifiers

PMID: 26392415
DOI: 10.18632/oncotarget.5193
PMCID: PMC4742011

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Concurrent radiotherapy with gefitinib in elderly patients with esophageal squamous cell carcinoma: Preliminary results of a phase II study.PMID 26392415Read ↗

A phase II study of concurrent chemoradiotherapy and erlotinib for inoperable esophageal squamous cell carcinoma.Semantic proximity Read ↗

Management of Patients With Adenocarcinoma or Squamous Cancer of the Esophagus.Semantic proximity Read ↗

Nrf2 promotes esophageal squamous cell carcinoma (ESCC) resistance to radiotherapy through the CaMKIIα-associated activation of autophagySemantic proximity Read ↗

Prognostic Factors Associated with 18 FDG-PET/CT in Esophageal Squamous Cell Carcinoma After Trimodality TreatmentSemantic proximity Read ↗

RAD18 confers radioresistance of esophagus squamous cell carcinoma through regulating p‐DNA‐PKcsSemantic proximity Read ↗

Phase II study of cetuximab plus concomitant boost radiotherapy in Japanese patients with locally advanced squamous cell carcinoma of the head and neck.Semantic proximity Read ↗

Small-molecule survivin inhibitor YM155 enhances radiosensitization in esophageal squamous cell carcinoma by the abrogation of G2 checkpoint and suppression of homologous recombination repairSemantic proximity Read ↗

Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53.Semantic proximity Read ↗

A phase 2 trial of erlotinib in patients with previously treated squamous cell and adenocarcinoma of the esophagus.Semantic proximity Read ↗

A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck.Semantic proximity Read ↗

Sequence-dependent effects of ZD1839 (‘Iressa’) in combination with cytotoxic treatment in human head and neck cancerSemantic proximity Read ↗

Associations of ATM Polymorphisms With Survival in Advanced Esophageal Squamous Cell Carcinoma Patients Receiving Radiation Therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.